10 January 2018 - History will record 2017 as a transformative year in medicine.
The U.S. approved the first gene therapy that modifies a patient’s blood cells to help the immune system attack an aggressive form of leukaemia in children and young adults.
Another breakthrough gene therapy was approved for a common form of lymphoma in adults, and the green light was given for a therapy that for the first time targets a specific genetic mutation.